Analyst Price Target is $266.70
▲ +24.87% Upside Potential
This price target is based on 11 analysts offering 12 month price targets for ICON Public in the last 3 months. The average price target is $266.70, with a high forecast of $290.00 and a low forecast of $250.00. The average price target represents a 24.87% upside from the last price of $213.59.
Current Consensus is
The current consensus among 11 polled investment analysts is to buy stock in ICON Public. This Buy consensus rating has held steady for over two years.
ICON plc operates as a clinical research organization, which engages in the provision of outsourced development services to the pharmaceutical, biotechnology, and medical device industries. It specializes in the strategic development, management and analysis of programs that support clinical development. It operates through the following geographical segments: Ireland, Rest of Europe, U.S. and Other. The company was founded by John Climax and Ronan Lambe in June 1990 and is headquartered in Dublin, Ireland.